It’s the news most MMA fans were dreading, Jon Jones’ “B” sample was tested and the results are the same as the “A” sample, positive for the steroid Turinabol. The news was first reported by ESPN.
Jon Jones had failed his original test back in July, one day before his fight with Daniel Cormier at UFC 214. He would go on to fight at UFC 214, where he defeated Cormier by third round TKO to reclaim the light-heavyweight title he had lost due to a hit-and-run back in April 2015. Jones and his camp denied any wrong doing and although it was a long shot, Jones and his team had the “B” sample tested in case it had been tainted.
Jon Jones following his knockout victory over Daniel Cormier at UFC 214. Credit – Matthew Wells
So, what is this “B” sample and why is it a long shot? Well, when a fighter gives his urine sample to USADA, the sample is taken in split into two, the “A” sample and the “B” sample. The “A” sample is tested and if it comes back positive for PED’s the fighter is then given the option to test the “B” sample in case the “A” sample may have been tainted somehow.
Unfortunately for Jones, this was not the first time he had failed a drug test for a banned substance. He had originally failed a test prior to UFC 200 which resulted in him being pulled from the main event against Daniel Cormier and having his interim light-heavy weight championship belt stripped from him.
Multiple reports had announced that Jones had passed a blood test leading up to UFC 214, although many had been hopeful that this meant he would be cleared of any wrong doing, it later came to light that the blood test would not be able to detect Turinabol and thus, meant Jones was still in trouble.
The UFC has not announced whether or not Jones would be stripped of the light-heavyweight belt. The California State Athletic Commission also has yet to announce whether the bout would become a No-Contest. USADA and the CSAC are expected to announce potential suspension lengths in the coming days.